Metalytics’ Metabolic Flux Analysis (MFA) technology provides cell factory analysis and is the basis for our monitoring and control platform. Metalytics CoreMFA is our technology-enabled packaged services offering which enables customers to optimize cell line selection, as well as determines optimal conditions for cell line production We optimize biomanufacturing processes by: Modeling metabolic reaction rates in the customers’ cell factories Deploying metabolic flux analysis with advanced software systems Accelerating client R&D and process improvement Improving productivity and solving complex production issues Increased return on investment and profitability through: Reduced time to market Increased production capacity More productive cell lines Reduced raw material costs
| Website | http://www.metalyticsbio.com |
| Employees | 9 (5 on RocketReach) |
| Founded | 2016 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+8 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Biotechnology, Cell Line Development, Bioprocess Optimization, Fermentation Optimization, Process Monitoring, Process Control, Biomanufacturing, Pharmaceutical Manufacturing, Bioprocess Development, Upstream Processing, Downstream Processing, Analytical Services, Technology Platform, Packaged Services, Data Analytics, Biosensors |
| Competitors | Roche, Thermo Fisher Scientific, Merck Group, Agilent Technologies, Illumina, PerkinElmer, Inc., Bio-Rad Laboratories, QIAGEN, Hudson Robotics, Inc., KPL +42 more (view full list) |
Looking for a particular Metalytics employee's phone or email?
Eric Cumming is the CEO of Metalytics.
5 people are employed at Metalytics.